Enhanced effectiveness of photodynamic therapy with laser light fractionation in patients with esophageal cancer

Endoscopy

Volumn 29, Issue 4, 1997, Pages 275-280

  Messmann, H ^a   Szeimies, R M ^a   Baumler W ^a   Knuchel R ^a   Zirngibl, H ^a   Scholmerich J ^a   Holstege, A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPORPHYRIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DYSPHAGIA; EARLY CANCER; ESOPHAGUS CANCER; ESOPHAGUS STENOSIS; FEMALE; HUMAN; LASER; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REMISSION; STENT; TUMOR GROWTH;

EID: 0030879521     PISSN: 0013726X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1004189     Document Type: Article

References (32)

1. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in the photoactivation of a murine tumor. Cancer Res 1976; 36: 2326-9.
2. Bown SG. Photodynamic therapy to scientists and clinicians: one world or two? J Photochem Photobiol B 1990; 6: 1-12.
3. Dougherty TJ, Cooper MT, Mang TS. Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Med Surg 1990; 10: 485-8.
4. Kennedy JC, Pottier RH. Endogenous protoporphyrin IX: a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275-92.
5. Regula J, MacRobert AJ, Gorhein A, Buonaccorsi GA, Thorpe SM, Spencer GM, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumors using 5-aminolaevulinic acid-induced protoporphyrin IX. Gut 1995; 36: 67-75.
6. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br J Cancer 1993; 68: 41-51.
7. Bedwell J, MacRobert AJ, Phillips D, Bown SG. Fluorescence distribution and photodynamic effect of ALA-induced PPIX in the DMH rat colonic tumor model. Br J Cancer 1992; 65: 818-24.
8. Barr H, Tralau CJ, Boulos PB, MacRobert AJ, Krasner N, Phillips D, et al. Selective necrosis in dimethyl hydrazine-induced rat colon tumors using phthalocyanine photodynamic therapy. Gastroenterology 1990; 98: 1532-1537.
9. Mlkvy P, Messmann H, Pauer M, Stewart JCM, Millson CE, MacRobert AJ, et al. Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent tissues in the Syrian golden hamster. Br J Cancer 1996; 73: 1473-9.
10. Heier SK, Rothman KA, Heier LM, Rosenthal WS. Photodynamic therapy for obstructing esophageal cancer: light dosimetry and randomized comparison with Nd:YAG laser therapy. Gastroenterology 1995; 109: 63-72.
11. Sibille A, Lambert R, Souquet JC, Sabben G, Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 1995; 108: 337-44.
12. Heier SK. Photodynamic therapy for esophageal malignancies. In: Barkin JS, O'Phelan CA, editors. Advanced therapeutic endoscopy. 2nd ed. New York: Raven Press, 1994: 57-63.
13. Gossner L, Wittke H, Warzecha A, Ernst H, Sroka R, Hahn EG, et al. Dose-dependent destruction of human gastrointestinal neoplasms by photodynamic therapy: a quantitative pilot study in athymic nude mice. Eur J Gastroenterol Hepatol 1994; 6: 159-65.
14. Thomas RJ, Abbott M, Bathal PS, John DJBS, Moryston G. High-dose photoradiation of esophageal cancer. Ann Surg 1987; 206: 193-9.
15. Messmann H, Mlkvy P, Buonaccorsi G, Davies CL, MacRobert AJ, Bown SG. Enhancement of photodynamic therapy with 5-aminolaevulinic acid-induced porphyrin photosensitisation in normal rat colon by threshold and light fractionation studies. Br J Cancer 1995; 72: 589-94.
16. Gossner L, Wittke H, Warzecha A, Sroka R, Ernst H, Meier M, et al. Verapamil and hematoporphyrin derivative for tumour destruction by photodynamic therapy. Br J Cancer 1991; 64: 84-6.
17. Rougee M, Bensasson RV, Land EJ, Pariente R. Deactivation of singlet molecular oxygen by thiols and related compounds: possible protectors against skin photosensitivity. Photochem Photobiol 1988; 47: 485-9.
18. Truscott TG. The use of all-trans beta-carotene to ameliorate PDT-induced skin photosensitivity. J Photochem Photobiol 1991; 11: 381-2.
19. Abulafi AM, Allardice JT, Woods WG, Williams NS. Cutaneous phototoxicity in photodynamic therapy: clinical experience with and without histamine antagonists. Lasers Med Sci 1991; 6: 179-82.
20. Van der Veen, Van Leengoed HLLM, Star WM. In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. Br J Cancer 1994; 70: 867-72.
21. Pe BM, Ikeda H, Inokuchi T. Tumor destruction and proliferation kinetics following periodic low-power light haematoporphyrin oligomers-mediated photodynamic therapy in the mouse tongue. Oral Oncol Eur J Cancer 1994; 30: 174-8.
22. Sroka R, Beyer W, Krug M, Noack A, Unsöld E, Ell C. Laser light application and monitoring for photodynamic therapy in hollow organs. Lasers Med Sci 1993; 8: 63-8.
23. Gossner L, Sroka R, Hahn EG, Ell C. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastrointest Endosc 1995; 41: 55-8.
24. Selman SH, Kreimer-Birnbaum M, Klaunig JE, Goldblatt PJ, Keck RW, Britton SL. Blood flow in transplantable bladder tumors treated with hematoporphyrin derivative and light. Cancer Res 1984; 44: 1924-7.
25. Wieman TJ, Mang TS, Fingar VH. Effect of photodynamic therapy on blood flow in normal and tumor vessels. Surgery 1988; 104: 512-7.
26. Henderson BW, Waldow SM, Mang TS, Potter RW, Malone PB, Dougherty TJ. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985; 45: 1924.
27. Star WM, Marijnssen HPA, Van den Berg-Blok AE, Versteeg JAC, Franken KAP, Reinholds HS. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin-derivative photoradiation observed in in-vivo sandwich observation chambers. Cancer Res 1986; 46: 2532-0.
28. Bown SG, Tralau CJ, Coleridge Smith PD, Akdemir D, Wieman TJ. Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br J Cancer 1986; 54: 43-52.
29. Szeimies RM, Abels C, Fritsch C, Karrer S, Steinbach P, Bäumler W, et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. J Invest Dermatol 1995; 105: 672-7.
30. Chang SC, MacRobert AJ, Porter JB, Bown SG. The effect of 1,2-diethyl-3-hydroxypyridine-4-one on tissue build-up of protoporphyrin IX: a microscopic quantitative fluorescence study on rat urinary bladder. SPIE Proc. 1995; 2371: 322-6.
31. Tan WC, Krasner N, O'Tode P, Lombard M. Enhancement of photodynamic therapy in gastric and colonic carcinoma cells by removal of iron. Gastroenterology 1995: 108; A544.
32. Messmann H, Holstege A, Szeimies RM, Geisler M, Köllinger M, Landthaler M, et al. Combination of 5-aminolaevulinic acid and a hematoporphyrin derivative in the photodynamic therapy of human colon carcinoma cells. Gastroenterology 1995; 108: 506 A.